![J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | Fierce Pharma J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1571685528/teva1_1.jpg/teva1_1.jpg?VersionId=DZxWIUBep5WwbJo2nfwehxGzs6STVv3O)
J&J, Teva offer a whopping $48B combined to wrap opioid suits, but not all plaintiffs are on board | Fierce Pharma
![Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times](https://img.etimg.com/photo/msid-54696649,quality-100/.jpg)
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times
![Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times Intas buys Teva's UK & Ireland assets for $764 million to break into global top 20 generic players club - The Economic Times](https://m.economictimes.com/thumb/msid-54704852,width-640,height-480,resizemode-7/intas-buys-tevas-uk-ireland-assets-for-764-million-to-break-into-global-top-20-generic-players-club.jpg)